	Five-Year Survival Analyses on Non-Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Regimens Plus Surgery: A Propensity Score Matching, Real-World Cohort Study. Cancer Med Liu W, Deng Y, Lin Y, Lin Y, Zheng X, Su W, Xiao W, Shi Y, Zhang J, Chen X. PMID: 42839363 [PubMed - indexed for MEDLINE]
	Same-day diagnosis and robotic resection of rare primary pulmonary melanoma: a robotic bronchoscopy-guided approach. BMJ Case Rep Fontaine-Nicola A, Manueli Laos EG, Masrur MA, Kovitz KL, David O, Abdelhady K. PMID: 42838699 [PubMed - indexed for MEDLINE]
	The canine tumour micro-environment and advances in antitumour therapy in canine melanoma. Vet J Hindriks E, Mmjm Z, Ajam S, Broere F. PMID: 42838287 [PubMed - as supplied by publisher]
	Explainable AI framework for skin lesion imaging based cancer detection. PLoS One Tera SP, Chinthaginjala R, Natha P, Srinivasulu A, Al-Turjman F, Mohammad F. PMID: 42837382 [PubMed - indexed for MEDLINE]
	First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306). Nat Commun Yoon HH, Kato K, Raymond E, Hubner R, Shu Y, Pan Y, Park SR, Kojima T, Lin CY, Wyrwicz L, Tougeron D, Ishihara R, Wang K, Peng Y, Xu J. PMID: 42834033 [PubMed - indexed for MEDLINE]
	Poliosis predicts durable response to immune-checkpoint blockade in metastatic melanoma: a multicenter cohort study. J Immunother Cancer Brekner A, Mengoni M, Kött J, Lang BM, Lepper A, Veeser J, Dietzel J, Laubach N, Forschner A, Gebhardt C, Grabbe S, Stege H, Haist M. PMID: 42833860 [PubMed - indexed for MEDLINE]
	SkinFusionNet: Multi-backbone spatial fusion for robust and explainable melanoma classification. Photodiagnosis Photodyn Ther Ahmmed F, Rafsan RS, Mansib M, Akther A, Esika AE, Mohaimen-Bin-Noor. PMID: 42833605 [PubMed - as supplied by publisher]
	EffAtt-LungNet: An attention-guided EfficientNet framework for three-class lung histopathology classification. PLoS One Jamil MA, Awan MDA, Bukhari F, Missen MMS, Kajla NI. PMID: 42832554 [PubMed - indexed for MEDLINE]
	Beyond reduced intake: tumor metabolism and immune dysregulation drive cancer-related malnutrition in head and neck squamous cell carcinoma (HNSCC). Support Care Cancer Zurlo V, Piccirillo A, Marciano ML, Pontone M, Rampetta FR, Perri E, Perri F. PMID: 42832090 [PubMed - indexed for MEDLINE]
	Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: a Multicenter Prospective Observational Study (COSMOS-MEL01). Cancer Res Commun Nakamura Y, Namikawa K, Ogata D, Nakano E, Komada A, Takahashi A, Yoshikawa S, Notake C, Mitani R, Yoshino T. PMID: 42831872 [PubMed - as supplied by publisher]
	Concordance of p16 status between US-guided core needle biopsy and surgical specimens in oropharyngeal squamous cell carcinoma: A diagnostic accuracy study. Medicine (Baltimore) Lee D, Choi YJ, Song JS, Lee YS, Chung SR, Baek JH, Lee JH. PMID: 42826333 [PubMed - indexed for MEDLINE]
	Usefulness of 18F-fluorodeoxyglucose positron emission tomography for T1 esophageal squamous cell carcinoma. Medicine (Baltimore) Ryu DG, Choi CW, Kim SJ, Kim SJ, Park SB, Jang JO, Lee CM, Son BS. PMID: 42826281 [PubMed - indexed for MEDLINE]
	Biopsy Type and Metastatic Recurrence in Melanoma: A Cohort Study. J Drugs Dermatol QingYin M, Yu F, Umair MM, QingLan P, JiYin G, HaiYan D, JinPing Z, Yun C, YuanBo X. PMID: 42826144 [PubMed - indexed for MEDLINE]
	Anti-PD-1 Therapy and Long-Term Toxic Effects Among Patients With Melanoma. JAMA Netw Open Kankaria RA, Fankhauser R, Boutros A, Pinzon M, Bai K, Chen SC, Agbisit CB, Kalyan A, Lawless A, Long GV, Sullivan RJ, Mehnert JM, Rapisuwon S, Balko JM, Carlino MS, Menzies AM, Johnson DB. PMID: 42826021 [PubMed - indexed for MEDLINE]
	Melanoma Self-Detection is Not Melanoma Diagnosis: Rethinking the Role of Self-Skin Examination. J Cancer Educ De Giorgi V, Cecchi G, Perillo G, Fazzari F, Zuccaro B. PMID: 42825873 [PubMed - as supplied by publisher]
	Salivary metabolic profile in patients with oral squamous cell carcinoma and potentially malignant disorders. Clin Oral Investig Soiniemi L, Hyvärinen E, Mikkonen J, Jäsberg H, Kashyap B, Kullaa A. PMID: 42825825 [PubMed - indexed for MEDLINE]
	Targeting VISTA as a novel immunotherapy for skin cancer. Front Immunol Hou Y, Chen X, Chen C. PMID: 42824772 [PubMed - indexed for MEDLINE]
	Cancer immunoediting in the melanoma tumor microenvironment: from immune elimination to therapeutic resistance. Front Immunol Yan X, Zhang Q, Chen Z, Zhou H. PMID: 42824519 [PubMed - indexed for MEDLINE]
	Nanocarrier-Based Drug Delivery Systems for Remodeling the Melanoma Tumor Microenvironment. J Drug Target Wang H, Sun C, Wang H, Shen W, Ren G, Wang M. PMID: 42823820 [PubMed - as supplied by publisher]
	CT radiomics showed no improvement beyond volume dynamics for early lesion-level size response to immunotherapy in metastatic melanoma. Cancer Imaging Akbal S, Schepers JC, Op Gen Oorth PV, Bleymehl V, Schroth M, Winneknecht F, Machiraju D, Holzschuh JC, Zhang KS, Wohlfeil S, Ayx I, Schoenberg SO, Schlemmer HP, Hassel JC, Rotkopf LT. PMID: 42823717 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 145121

Page 1 of 7257



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy